IP Verse

Polymorphic Forms Of Rad1901-2Hcl - EP3565542

The patent EP3565542 was granted to Radius Pharmaceuticals on Apr 10, 2024. The application was originally filed on Jan 5, 2018 under application number EP18736577A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3565542

RADIUS PHARMACEUTICALS
Application Number
EP18736577A
Filing Date
Jan 5, 2018
Status
Granted And Under Opposition
Mar 8, 2024
Grant Date
Apr 10, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSJan 10, 2025VON KAUFFMANNADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2011124617
INTERNATIONAL-SEARCH-REPORTUS2013116232
INTERNATIONAL-SEARCH-REPORTWO2014203129
INTERNATIONAL-SEARCH-REPORTWO2016176665
OPPOSITIONEP1797038
OPPOSITIONUS7612114
OPPOSITIONWO2011143469
OTHERUS7612114
OTHERUS8399520
OTHERUS8933130
OTHERWO2016176665
SEARCHWO2016176665

Non-Patent Literature (NPL) Citations (8) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- BAVIN M, "Polymorphism in Process Development", Chemistry & Industry, SOCIETY OF CHEMICAL INDUSTRY. LONDON., GB, GB , (19890821), ISSN 0009-3068, pages 527 - 529, XP001180136-
OPPOSITION- D5 - T 0041/ 17 - 3.3.02-
OPPOSITION- D9 - T 0777/08 - 3.3.01-
OPPOSITION- Alfons Grunenberg, "Polymorphie und Thermische Analyse pharmazeutischer Wirkstoffe", Pharmazie in unserer Zeit, (19970101), vol. 26, no. 5, doi:10.1002/pauz.19970260506, pages 224 - 231, XP055745450
OPPOSITION- Stephen Byrn; Pfeiffer Ralph; Ganey Michael; Hoiberg Charles; Poochikian Guirag, "Pharmaceutical Solids: A strategic Approach to Regulatory Considerations", Pharmaceutical Research, Springer Berlin Heidelberg, Berlin/Heidelberg, Berlin/Heidelberg, (19950701), vol. 12, no. 07, doi:10.1023/A:1016241927429, ISSN 0724-8741, pages 945 - 954, XP000996386
OPPOSITION- Masum Zia Uddin, Spoors P. Grant, Cruskie Michael, Bolger Joshua, Mckenzie Jonathan, Sheth Pratik, Edwards Richard, Eberlin Alex, Markey Michael, Gupta Vivek, "Stability & Polymorphic Characterization of Elacestrant Dihydrochloride", Research Square, doi:10.21203/rs.3.rs-4580437/v1, Research Square, URL: https://assets-eu.researchsquare.com/files/rs-4580437/v1/b724b212-dbe2-460e-b1cc-69e3369198fe.pdf?c=1718607134, XP093254253
OTHER- Garner Fiona, Shomali Maysoun, Paquin Dotty, Lyttle C. Richard, Hattersley Gary, "RAD1901 : a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models", Anti-Cancer Drugs, US , (20151001), vol. 26, no. 9, doi:10.1097/CAD.0000000000000271, ISSN 0959-4973, pages 948 - 956, XP093093509
SEARCH- M.R. CAIRA, "Crystalline polymorphism of organic compounds", TOPICS IN CURRENT CHEMISTRY, Springer Verlag, Berlin, DE, (1998), vol. 198, doi:10.1007/3-540-69178-2_5, ISSN 0340-1022, pages 163 - 208, XP001156954 [Y] 1-14 * pages 165-166 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents